These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Steensma DP; Bejar R; Jaiswal S; Lindsley RC; Sekeres MA; Hasserjian RP; Ebert BL Blood; 2015 Jul; 126(1):9-16. PubMed ID: 25931582 [TBL] [Abstract][Full Text] [Related]
11. Early detection and intervention of clonal hematopoiesis for preventing hematological malignancies. Ye B; Sheng Y; Zhang M; Hu Y; Huang H Cancer Lett; 2022 Jul; 538():215691. PubMed ID: 35469959 [TBL] [Abstract][Full Text] [Related]
12. Clinical consequences of clonal hematopoiesis of indeterminate potential. Steensma DP Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):264-269. PubMed ID: 30504320 [TBL] [Abstract][Full Text] [Related]
14. Clonal hematopoiesis and risk for hematologic malignancy. Warren JT; Link DC Blood; 2020 Oct; 136(14):1599-1605. PubMed ID: 32736382 [TBL] [Abstract][Full Text] [Related]
15. Role of p53 in regulation of hematopoiesis in health and disease. Barajas S; Cai W; Liu Y Curr Opin Hematol; 2022 Jul; 29(4):194-200. PubMed ID: 35787548 [TBL] [Abstract][Full Text] [Related]
16. Defining clonal hematopoiesis of indeterminate potential: evolutionary dynamics and detection under aging and inflammation. Goldman EA; Spellman PT; Agarwal A Cold Spring Harb Mol Case Stud; 2023 Apr; 9(2):. PubMed ID: 36889927 [TBL] [Abstract][Full Text] [Related]
17. Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes. Coombs CC; Zehir A; Devlin SM; Kishtagari A; Syed A; Jonsson P; Hyman DM; Solit DB; Robson ME; Baselga J; Arcila ME; Ladanyi M; Tallman MS; Levine RL; Berger MF Cell Stem Cell; 2017 Sep; 21(3):374-382.e4. PubMed ID: 28803919 [TBL] [Abstract][Full Text] [Related]
18. Review of clonal hematopoiesis, subtypes and its role in neoplasia and different morbidities. Younes IE; Syler L; Hamed A Leuk Res; 2023 Jul; 130():107307. PubMed ID: 37186988 [TBL] [Abstract][Full Text] [Related]
19. How predictive is the finding of clonal hematopoiesis for the development of myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML)? Steensma DP Best Pract Res Clin Haematol; 2021 Dec; 34(4):101327. PubMed ID: 34865699 [TBL] [Abstract][Full Text] [Related]
20. Clonal hematopoiesis as a model for premalignant changes during aging. Steensma DP; Ebert BL Exp Hematol; 2020 Mar; 83():48-56. PubMed ID: 31838005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]